Aaron Y Mochizuki

8PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersSolid tumoursMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 17, 2026
Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma.

|Feb 07, 2022
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.

Robbie G Majzner, Sneha Ramakrishna, Kristen W Yeom

|Nov 27, 2021
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma.

Alexander H Lee, Lu Sun, Aaron Y Mochizuki

|Jun 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.

Erik Ladomersky, Lijie Zhai, Kristen L Lauing

|Feb 12, 2019
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla

|Dec 01, 2018
Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation.

Tom B Davidson, Alexander Lee, Melody Hsu

Pageof 2

Frequent Collaborators

3 joint publications

Alexander Lee

3 joint publications

Joey R Orpilla

3 joint publications

Robert M Prins

2 joint publications

Timothy F Cloughesy